Checking ROIV unusual options activity helps you spot when traders are making outsized bets on Roivant Sciences Ltd before the broader market catches on. Roivant Sciences Ltd's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ROIV unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ROIV unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ROIV unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ROIV unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Catalysts rarely arrive without a footprint, and ROIV unusual options activity is often where that footprint shows up first. Our scanner tracks Roivant Sciences Ltd's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ROIV unusual options volume on the call side or chasing put sweeps, Roivant Sciences Ltd's unusual options flow today is one click away, so put it on your radar before the headlines hit.
